Novo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection in April finding mammalian hair in finished drugs and water leaks that compromise product sterility.
Novo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection in April finding mammalian hair in …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Novo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection…
Eighteen months after Novo Nordisk purchased a plant in the | Eighteen months after Novo Nordisk purchased a plant in the Czech…
A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a standoff.…
HYDERABAD, India, June 30, 2026 /PRNewswire/ -- Shantha Biologics today announced that it has entered into an outsourcing…
Novo Nordisk invests ~$380M in Czech manufacturing and $29.4M in China; Cellares grows Series D to $327M; Eisai gets support;…
Hacking group FulcrumSec claims it stole Novo Nordisk AI models and drug manufacturing secrets and tried to sell them after Novo…
